nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxetine—ALB—systemic lupus erythematosus	0.188	1	CbGaD
Fluoxetine—ALB—Mycophenolate mofetil—systemic lupus erythematosus	0.0271	0.0538	CbGbCtD
Fluoxetine—CYP1A2—Leflunomide—systemic lupus erythematosus	0.0263	0.0521	CbGbCtD
Fluoxetine—CYP3A5—Dapsone—systemic lupus erythematosus	0.0251	0.0499	CbGbCtD
Fluoxetine—CYP2C9—Leflunomide—systemic lupus erythematosus	0.0237	0.047	CbGbCtD
Fluoxetine—CYP3A5—Mycophenolate mofetil—systemic lupus erythematosus	0.0218	0.0433	CbGbCtD
Fluoxetine—ALB—Prednisone—systemic lupus erythematosus	0.0217	0.043	CbGbCtD
Fluoxetine—CYP2C19—Dapsone—systemic lupus erythematosus	0.0203	0.0402	CbGbCtD
Fluoxetine—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.0187	0.0372	CbGbCtD
Fluoxetine—CYP3A5—Hydrocortisone—systemic lupus erythematosus	0.0175	0.0347	CbGbCtD
Fluoxetine—CYP2C9—Dapsone—systemic lupus erythematosus	0.0169	0.0335	CbGbCtD
Fluoxetine—CYP3A5—Cyclosporine—systemic lupus erythematosus	0.0165	0.0328	CbGbCtD
Fluoxetine—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.0142	0.0282	CbGbCtD
Fluoxetine—CYP2C19—Prednisone—systemic lupus erythematosus	0.0141	0.0279	CbGbCtD
Fluoxetine—CYP2B6—Dexamethasone—systemic lupus erythematosus	0.0138	0.0274	CbGbCtD
Fluoxetine—CYP2C19—Cyclosporine—systemic lupus erythematosus	0.0133	0.0264	CbGbCtD
Fluoxetine—ABCB1—Betamethasone—systemic lupus erythematosus	0.0122	0.0242	CbGbCtD
Fluoxetine—ABCB1—Prednisolone—systemic lupus erythematosus	0.012	0.0238	CbGbCtD
Fluoxetine—HTR2C—choroid plexus—systemic lupus erythematosus	0.0117	0.175	CbGeAlD
Fluoxetine—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.0114	0.0226	CbGbCtD
Fluoxetine—ABCB1—Prednisone—systemic lupus erythematosus	0.0113	0.0225	CbGbCtD
Fluoxetine—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.0112	0.0223	CbGbCtD
Fluoxetine—CYP2C9—Cyclosporine—systemic lupus erythematosus	0.0111	0.022	CbGbCtD
Fluoxetine—CYP3A5—Dexamethasone—systemic lupus erythematosus	0.0109	0.0216	CbGbCtD
Fluoxetine—ALB—Methotrexate—systemic lupus erythematosus	0.0109	0.0216	CbGbCtD
Fluoxetine—ABCB1—Cyclosporine—systemic lupus erythematosus	0.0108	0.0213	CbGbCtD
Fluoxetine—CYP2D6—Cyclosporine—systemic lupus erythematosus	0.0101	0.0201	CbGbCtD
Fluoxetine—CYP3A4—Dapsone—systemic lupus erythematosus	0.00981	0.0195	CbGbCtD
Fluoxetine—CYP2C9—cardial valve—systemic lupus erythematosus	0.00884	0.132	CbGeAlD
Fluoxetine—CYP2C19—Dexamethasone—systemic lupus erythematosus	0.00878	0.0174	CbGbCtD
Fluoxetine—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.0085	0.0169	CbGbCtD
Fluoxetine—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.0085	0.0169	CbGbCtD
Fluoxetine—CYP2C9—Dexamethasone—systemic lupus erythematosus	0.0073	0.0145	CbGbCtD
Fluoxetine—CYP3A4—Betamethasone—systemic lupus erythematosus	0.00729	0.0145	CbGbCtD
Fluoxetine—CYP3A4—Prednisolone—systemic lupus erythematosus	0.0072	0.0143	CbGbCtD
Fluoxetine—ABCB1—Dexamethasone—systemic lupus erythematosus	0.00708	0.0141	CbGbCtD
Fluoxetine—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.00682	0.0135	CbGbCtD
Fluoxetine—CYP3A4—Prednisone—systemic lupus erythematosus	0.0068	0.0135	CbGbCtD
Fluoxetine—CYP2D6—Dexamethasone—systemic lupus erythematosus	0.00667	0.0132	CbGbCtD
Fluoxetine—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.00644	0.0128	CbGbCtD
Fluoxetine—HTR2A—choroid plexus—systemic lupus erythematosus	0.00587	0.0879	CbGeAlD
Fluoxetine—ABCB1—Methotrexate—systemic lupus erythematosus	0.00569	0.0113	CbGbCtD
Fluoxetine—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.00424	0.00842	CbGbCtD
Fluoxetine—CYP2C19—urine—systemic lupus erythematosus	0.00246	0.0368	CbGeAlD
Fluoxetine—CYP1A2—urine—systemic lupus erythematosus	0.00201	0.0301	CbGeAlD
Fluoxetine—CYP2C9—urine—systemic lupus erythematosus	0.00191	0.0286	CbGeAlD
Fluoxetine—HTR2A—urine—systemic lupus erythematosus	0.00157	0.0235	CbGeAlD
Fluoxetine—SLC6A4—blood plasma—systemic lupus erythematosus	0.00155	0.0232	CbGeAlD
Fluoxetine—CYP3A4—urine—systemic lupus erythematosus	0.00145	0.0218	CbGeAlD
Fluoxetine—CYP2D6—urine—systemic lupus erythematosus	0.00143	0.0214	CbGeAlD
Fluoxetine—CYP2C19—blood plasma—systemic lupus erythematosus	0.00128	0.0192	CbGeAlD
Fluoxetine—CYP1A2—blood plasma—systemic lupus erythematosus	0.00105	0.0157	CbGeAlD
Fluoxetine—CYP3A5—blood plasma—systemic lupus erythematosus	0.00101	0.0151	CbGeAlD
Fluoxetine—CYP2B6—blood plasma—systemic lupus erythematosus	0.001	0.015	CbGeAlD
Fluoxetine—CYP2C9—blood plasma—systemic lupus erythematosus	0.000995	0.0149	CbGeAlD
Fluoxetine—HTR2A—endothelium—systemic lupus erythematosus	0.000922	0.0138	CbGeAlD
Fluoxetine—SIGMAR1—Levonorgestrel—Hydrocortisone—systemic lupus erythematosus	0.00086	1	CbGdCrCtD
Fluoxetine—HTR2A—blood plasma—systemic lupus erythematosus	0.000819	0.0123	CbGeAlD
Fluoxetine—SIGMAR1—nephron tubule—systemic lupus erythematosus	0.000793	0.0119	CbGeAlD
Fluoxetine—CYP3A4—blood plasma—systemic lupus erythematosus	0.000758	0.0114	CbGeAlD
Fluoxetine—CYP2D6—blood plasma—systemic lupus erythematosus	0.000746	0.0112	CbGeAlD
Fluoxetine—SIGMAR1—cortex of kidney—systemic lupus erythematosus	0.000679	0.0102	CbGeAlD
Fluoxetine—ORM1—bone marrow—systemic lupus erythematosus	0.000644	0.00965	CbGeAlD
Fluoxetine—ORM1—lung—systemic lupus erythematosus	0.000584	0.00874	CbGeAlD
Fluoxetine—SIGMAR1—tendon—systemic lupus erythematosus	0.000563	0.00843	CbGeAlD
Fluoxetine—SIGMAR1—bone marrow—systemic lupus erythematosus	0.000545	0.00817	CbGeAlD
Fluoxetine—ORM1—nervous system—systemic lupus erythematosus	0.00054	0.0081	CbGeAlD
Fluoxetine—ABCB1—blood plasma—systemic lupus erythematosus	0.000537	0.00804	CbGeAlD
Fluoxetine—CYP3A5—nephron tubule—systemic lupus erythematosus	0.000521	0.00781	CbGeAlD
Fluoxetine—ORM1—central nervous system—systemic lupus erythematosus	0.00052	0.0078	CbGeAlD
Fluoxetine—CYP2B6—nephron tubule—systemic lupus erythematosus	0.000518	0.00776	CbGeAlD
Fluoxetine—SLC6A4—lung—systemic lupus erythematosus	0.000497	0.00745	CbGeAlD
Fluoxetine—SIGMAR1—lung—systemic lupus erythematosus	0.000494	0.0074	CbGeAlD
Fluoxetine—HTR2C—nervous system—systemic lupus erythematosus	0.000486	0.00728	CbGeAlD
Fluoxetine—CYP2B6—skin of body—systemic lupus erythematosus	0.000483	0.00724	CbGeAlD
Fluoxetine—HTR2C—central nervous system—systemic lupus erythematosus	0.000468	0.00701	CbGeAlD
Fluoxetine—SLC6A4—nervous system—systemic lupus erythematosus	0.00046	0.0069	CbGeAlD
Fluoxetine—CYP3A5—kidney—systemic lupus erythematosus	0.000458	0.00686	CbGeAlD
Fluoxetine—CYP2B6—kidney—systemic lupus erythematosus	0.000455	0.00682	CbGeAlD
Fluoxetine—CYP3A5—cortex of kidney—systemic lupus erythematosus	0.000446	0.00668	CbGeAlD
Fluoxetine—SLC6A4—central nervous system—systemic lupus erythematosus	0.000443	0.00664	CbGeAlD
Fluoxetine—SLC6A2—lung—systemic lupus erythematosus	0.000438	0.00656	CbGeAlD
Fluoxetine—HTR2A—connective tissue—systemic lupus erythematosus	0.000436	0.00654	CbGeAlD
Fluoxetine—SLC6A2—nervous system—systemic lupus erythematosus	0.000405	0.00607	CbGeAlD
Fluoxetine—CYP2B6—lymphoid tissue—systemic lupus erythematosus	0.000391	0.00586	CbGeAlD
Fluoxetine—SLC6A2—central nervous system—systemic lupus erythematosus	0.00039	0.00585	CbGeAlD
Fluoxetine—HTR2A—kidney—systemic lupus erythematosus	0.000371	0.00556	CbGeAlD
Fluoxetine—CYP3A4—kidney—systemic lupus erythematosus	0.000344	0.00515	CbGeAlD
Fluoxetine—CYP2D6—kidney—systemic lupus erythematosus	0.000338	0.00507	CbGeAlD
Fluoxetine—CYP1A2—lung—systemic lupus erythematosus	0.000336	0.00504	CbGeAlD
Fluoxetine—CYP3A5—lung—systemic lupus erythematosus	0.000325	0.00486	CbGeAlD
Fluoxetine—CYP2B6—lung—systemic lupus erythematosus	0.000323	0.00483	CbGeAlD
Fluoxetine—HTR2A—tendon—systemic lupus erythematosus	0.0003	0.00449	CbGeAlD
Fluoxetine—CYP2B6—nervous system—systemic lupus erythematosus	0.000299	0.00448	CbGeAlD
Fluoxetine—CYP2B6—central nervous system—systemic lupus erythematosus	0.000288	0.00431	CbGeAlD
Fluoxetine—ABCB1—nephron tubule—systemic lupus erythematosus	0.000277	0.00415	CbGeAlD
Fluoxetine—HTR2A—lung—systemic lupus erythematosus	0.000263	0.00394	CbGeAlD
Fluoxetine—HTR2A—nervous system—systemic lupus erythematosus	0.000244	0.00365	CbGeAlD
Fluoxetine—ABCB1—kidney—systemic lupus erythematosus	0.000243	0.00365	CbGeAlD
Fluoxetine—ABCB1—cortex of kidney—systemic lupus erythematosus	0.000237	0.00355	CbGeAlD
Fluoxetine—HTR2A—central nervous system—systemic lupus erythematosus	0.000235	0.00351	CbGeAlD
Fluoxetine—CYP3A4—nervous system—systemic lupus erythematosus	0.000226	0.00338	CbGeAlD
Fluoxetine—CYP2D6—nervous system—systemic lupus erythematosus	0.000222	0.00333	CbGeAlD
Fluoxetine—CYP3A4—central nervous system—systemic lupus erythematosus	0.000217	0.00325	CbGeAlD
Fluoxetine—CYP2D6—central nervous system—systemic lupus erythematosus	0.000214	0.0032	CbGeAlD
Fluoxetine—ABCB1—lymphoid tissue—systemic lupus erythematosus	0.000209	0.00313	CbGeAlD
Fluoxetine—ABCB1—bone marrow—systemic lupus erythematosus	0.00019	0.00285	CbGeAlD
Fluoxetine—ABCB1—lung—systemic lupus erythematosus	0.000172	0.00258	CbGeAlD
Fluoxetine—ABCB1—nervous system—systemic lupus erythematosus	0.00016	0.00239	CbGeAlD
Fluoxetine—ABCB1—central nervous system—systemic lupus erythematosus	0.000154	0.0023	CbGeAlD
Fluoxetine—Hepatitis—Methotrexate—systemic lupus erythematosus	5.24e-05	0.000218	CcSEcCtD
Fluoxetine—Haemorrhage—Methotrexate—systemic lupus erythematosus	5.24e-05	0.000218	CcSEcCtD
Fluoxetine—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	5.22e-05	0.000217	CcSEcCtD
Fluoxetine—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	5.2e-05	0.000217	CcSEcCtD
Fluoxetine—Pharyngitis—Methotrexate—systemic lupus erythematosus	5.2e-05	0.000217	CcSEcCtD
Fluoxetine—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	5.19e-05	0.000216	CcSEcCtD
Fluoxetine—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	5.19e-05	0.000216	CcSEcCtD
Fluoxetine—Nausea—Leflunomide—systemic lupus erythematosus	5.18e-05	0.000216	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	5.17e-05	0.000215	CcSEcCtD
Fluoxetine—Fatigue—Hydrocortisone—systemic lupus erythematosus	5.16e-05	0.000215	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	5.13e-05	0.000214	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	5.12e-05	0.000213	CcSEcCtD
Fluoxetine—Pain—Hydrocortisone—systemic lupus erythematosus	5.12e-05	0.000213	CcSEcCtD
Fluoxetine—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	5.11e-05	0.000213	CcSEcCtD
Fluoxetine—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	5.11e-05	0.000213	CcSEcCtD
Fluoxetine—Insomnia—Triamcinolone—systemic lupus erythematosus	5.1e-05	0.000212	CcSEcCtD
Fluoxetine—Insomnia—Methylprednisolone—systemic lupus erythematosus	5.09e-05	0.000212	CcSEcCtD
Fluoxetine—Infection—Dexamethasone—systemic lupus erythematosus	5.08e-05	0.000212	CcSEcCtD
Fluoxetine—Infection—Betamethasone—systemic lupus erythematosus	5.08e-05	0.000212	CcSEcCtD
Fluoxetine—Ill-defined disorder—Prednisone—systemic lupus erythematosus	5.06e-05	0.000211	CcSEcCtD
Fluoxetine—Paraesthesia—Triamcinolone—systemic lupus erythematosus	5.06e-05	0.000211	CcSEcCtD
Fluoxetine—Feeling abnormal—Prednisolone—systemic lupus erythematosus	5.05e-05	0.00021	CcSEcCtD
Fluoxetine—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	5.05e-05	0.00021	CcSEcCtD
Fluoxetine—Visual impairment—Methotrexate—systemic lupus erythematosus	5.05e-05	0.00021	CcSEcCtD
Fluoxetine—Anaemia—Prednisone—systemic lupus erythematosus	5.04e-05	0.00021	CcSEcCtD
Fluoxetine—Shock—Dexamethasone—systemic lupus erythematosus	5.03e-05	0.00021	CcSEcCtD
Fluoxetine—Shock—Betamethasone—systemic lupus erythematosus	5.03e-05	0.00021	CcSEcCtD
Fluoxetine—Dyspnoea—Triamcinolone—systemic lupus erythematosus	5.02e-05	0.000209	CcSEcCtD
Fluoxetine—Agitation—Prednisone—systemic lupus erythematosus	5.01e-05	0.000209	CcSEcCtD
Fluoxetine—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	5.01e-05	0.000209	CcSEcCtD
Fluoxetine—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	5.01e-05	0.000209	CcSEcCtD
Fluoxetine—Tachycardia—Dexamethasone—systemic lupus erythematosus	4.99e-05	0.000208	CcSEcCtD
Fluoxetine—Tachycardia—Betamethasone—systemic lupus erythematosus	4.99e-05	0.000208	CcSEcCtD
Fluoxetine—Angioedema—Prednisone—systemic lupus erythematosus	4.99e-05	0.000208	CcSEcCtD
Fluoxetine—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	4.96e-05	0.000207	CcSEcCtD
Fluoxetine—Dyspepsia—Triamcinolone—systemic lupus erythematosus	4.96e-05	0.000207	CcSEcCtD
Fluoxetine—Erythema multiforme—Methotrexate—systemic lupus erythematosus	4.95e-05	0.000206	CcSEcCtD
Fluoxetine—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	4.95e-05	0.000206	CcSEcCtD
Fluoxetine—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	4.94e-05	0.000206	CcSEcCtD
Fluoxetine—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	4.94e-05	0.000206	CcSEcCtD
Fluoxetine—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	4.93e-05	0.000206	CcSEcCtD
Fluoxetine—Malaise—Prednisone—systemic lupus erythematosus	4.92e-05	0.000205	CcSEcCtD
Fluoxetine—Vertigo—Prednisone—systemic lupus erythematosus	4.9e-05	0.000204	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	4.89e-05	0.000204	CcSEcCtD
Fluoxetine—Syncope—Prednisone—systemic lupus erythematosus	4.89e-05	0.000204	CcSEcCtD
Fluoxetine—Tinnitus—Methotrexate—systemic lupus erythematosus	4.88e-05	0.000204	CcSEcCtD
Fluoxetine—Anorexia—Dexamethasone—systemic lupus erythematosus	4.87e-05	0.000203	CcSEcCtD
Fluoxetine—Anorexia—Betamethasone—systemic lupus erythematosus	4.87e-05	0.000203	CcSEcCtD
Fluoxetine—Urticaria—Prednisolone—systemic lupus erythematosus	4.87e-05	0.000203	CcSEcCtD
Fluoxetine—Fatigue—Triamcinolone—systemic lupus erythematosus	4.86e-05	0.000202	CcSEcCtD
Fluoxetine—Fatigue—Methylprednisolone—systemic lupus erythematosus	4.85e-05	0.000202	CcSEcCtD
Fluoxetine—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	4.84e-05	0.000202	CcSEcCtD
Fluoxetine—Asthenia—Cyclosporine—systemic lupus erythematosus	4.83e-05	0.000201	CcSEcCtD
Fluoxetine—Pain—Triamcinolone—systemic lupus erythematosus	4.82e-05	0.000201	CcSEcCtD
Fluoxetine—Loss of consciousness—Prednisone—systemic lupus erythematosus	4.8e-05	0.0002	CcSEcCtD
Fluoxetine—Hypotension—Betamethasone—systemic lupus erythematosus	4.78e-05	0.000199	CcSEcCtD
Fluoxetine—Hypotension—Dexamethasone—systemic lupus erythematosus	4.78e-05	0.000199	CcSEcCtD
Fluoxetine—Pruritus—Cyclosporine—systemic lupus erythematosus	4.76e-05	0.000199	CcSEcCtD
Fluoxetine—Urticaria—Hydrocortisone—systemic lupus erythematosus	4.75e-05	0.000198	CcSEcCtD
Fluoxetine—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	4.73e-05	0.000197	CcSEcCtD
Fluoxetine—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	4.73e-05	0.000197	CcSEcCtD
Fluoxetine—Convulsion—Prednisone—systemic lupus erythematosus	4.73e-05	0.000197	CcSEcCtD
Fluoxetine—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	4.71e-05	0.000196	CcSEcCtD
Fluoxetine—Hypertension—Prednisone—systemic lupus erythematosus	4.71e-05	0.000196	CcSEcCtD
Fluoxetine—Chills—Methotrexate—systemic lupus erythematosus	4.7e-05	0.000196	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	4.66e-05	0.000194	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	4.66e-05	0.000194	CcSEcCtD
Fluoxetine—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	4.65e-05	0.000194	CcSEcCtD
Fluoxetine—Myalgia—Prednisone—systemic lupus erythematosus	4.65e-05	0.000194	CcSEcCtD
Fluoxetine—Arthralgia—Prednisone—systemic lupus erythematosus	4.65e-05	0.000194	CcSEcCtD
Fluoxetine—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	4.64e-05	0.000194	CcSEcCtD
Fluoxetine—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	4.63e-05	0.000193	CcSEcCtD
Fluoxetine—Anxiety—Prednisone—systemic lupus erythematosus	4.63e-05	0.000193	CcSEcCtD
Fluoxetine—Alopecia—Methotrexate—systemic lupus erythematosus	4.63e-05	0.000193	CcSEcCtD
Fluoxetine—Insomnia—Dexamethasone—systemic lupus erythematosus	4.63e-05	0.000193	CcSEcCtD
Fluoxetine—Insomnia—Betamethasone—systemic lupus erythematosus	4.63e-05	0.000193	CcSEcCtD
Fluoxetine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	4.61e-05	0.000192	CcSEcCtD
Fluoxetine—Diarrhoea—Cyclosporine—systemic lupus erythematosus	4.61e-05	0.000192	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	4.6e-05	0.000192	CcSEcCtD
Fluoxetine—Paraesthesia—Dexamethasone—systemic lupus erythematosus	4.59e-05	0.000191	CcSEcCtD
Fluoxetine—Paraesthesia—Betamethasone—systemic lupus erythematosus	4.59e-05	0.000191	CcSEcCtD
Fluoxetine—Discomfort—Prednisone—systemic lupus erythematosus	4.59e-05	0.000191	CcSEcCtD
Fluoxetine—Mental disorder—Methotrexate—systemic lupus erythematosus	4.59e-05	0.000191	CcSEcCtD
Fluoxetine—Malnutrition—Methotrexate—systemic lupus erythematosus	4.56e-05	0.00019	CcSEcCtD
Fluoxetine—Hypersensitivity—Prednisolone—systemic lupus erythematosus	4.52e-05	0.000188	CcSEcCtD
Fluoxetine—Dyspepsia—Dexamethasone—systemic lupus erythematosus	4.5e-05	0.000188	CcSEcCtD
Fluoxetine—Dyspepsia—Betamethasone—systemic lupus erythematosus	4.5e-05	0.000188	CcSEcCtD
Fluoxetine—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	4.5e-05	0.000187	CcSEcCtD
Fluoxetine—Urticaria—Triamcinolone—systemic lupus erythematosus	4.48e-05	0.000187	CcSEcCtD
Fluoxetine—Urticaria—Methylprednisolone—systemic lupus erythematosus	4.47e-05	0.000186	CcSEcCtD
Fluoxetine—Dysgeusia—Methotrexate—systemic lupus erythematosus	4.47e-05	0.000186	CcSEcCtD
Fluoxetine—Body temperature increased—Triamcinolone—systemic lupus erythematosus	4.46e-05	0.000186	CcSEcCtD
Fluoxetine—Dizziness—Cyclosporine—systemic lupus erythematosus	4.45e-05	0.000186	CcSEcCtD
Fluoxetine—Anaphylactic shock—Prednisone—systemic lupus erythematosus	4.45e-05	0.000186	CcSEcCtD
Fluoxetine—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	4.45e-05	0.000185	CcSEcCtD
Fluoxetine—Decreased appetite—Dexamethasone—systemic lupus erythematosus	4.45e-05	0.000185	CcSEcCtD
Fluoxetine—Decreased appetite—Betamethasone—systemic lupus erythematosus	4.45e-05	0.000185	CcSEcCtD
Fluoxetine—Infection—Prednisone—systemic lupus erythematosus	4.42e-05	0.000184	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	4.41e-05	0.000184	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	4.41e-05	0.000184	CcSEcCtD
Fluoxetine—Back pain—Methotrexate—systemic lupus erythematosus	4.41e-05	0.000184	CcSEcCtD
Fluoxetine—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	4.41e-05	0.000184	CcSEcCtD
Fluoxetine—Fatigue—Betamethasone—systemic lupus erythematosus	4.41e-05	0.000184	CcSEcCtD
Fluoxetine—Fatigue—Dexamethasone—systemic lupus erythematosus	4.41e-05	0.000184	CcSEcCtD
Fluoxetine—Shock—Prednisone—systemic lupus erythematosus	4.38e-05	0.000183	CcSEcCtD
Fluoxetine—Pain—Dexamethasone—systemic lupus erythematosus	4.37e-05	0.000182	CcSEcCtD
Fluoxetine—Pain—Betamethasone—systemic lupus erythematosus	4.37e-05	0.000182	CcSEcCtD
Fluoxetine—Tachycardia—Prednisone—systemic lupus erythematosus	4.35e-05	0.000181	CcSEcCtD
Fluoxetine—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	4.34e-05	0.000181	CcSEcCtD
Fluoxetine—Skin disorder—Prednisone—systemic lupus erythematosus	4.33e-05	0.00018	CcSEcCtD
Fluoxetine—Hyperhidrosis—Prednisone—systemic lupus erythematosus	4.31e-05	0.000179	CcSEcCtD
Fluoxetine—Asthenia—Hydrocortisone—systemic lupus erythematosus	4.29e-05	0.000179	CcSEcCtD
Fluoxetine—Vomiting—Cyclosporine—systemic lupus erythematosus	4.28e-05	0.000178	CcSEcCtD
Fluoxetine—Rash—Cyclosporine—systemic lupus erythematosus	4.25e-05	0.000177	CcSEcCtD
Fluoxetine—Anorexia—Prednisone—systemic lupus erythematosus	4.25e-05	0.000177	CcSEcCtD
Fluoxetine—Dermatitis—Cyclosporine—systemic lupus erythematosus	4.24e-05	0.000177	CcSEcCtD
Fluoxetine—Pruritus—Hydrocortisone—systemic lupus erythematosus	4.23e-05	0.000176	CcSEcCtD
Fluoxetine—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	4.23e-05	0.000176	CcSEcCtD
Fluoxetine—Headache—Cyclosporine—systemic lupus erythematosus	4.22e-05	0.000176	CcSEcCtD
Fluoxetine—Anaemia—Methotrexate—systemic lupus erythematosus	4.21e-05	0.000176	CcSEcCtD
Fluoxetine—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	4.21e-05	0.000176	CcSEcCtD
Fluoxetine—Feeling abnormal—Betamethasone—systemic lupus erythematosus	4.21e-05	0.000176	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	4.18e-05	0.000174	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	4.18e-05	0.000174	CcSEcCtD
Fluoxetine—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	4.18e-05	0.000174	CcSEcCtD
Fluoxetine—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	4.15e-05	0.000173	CcSEcCtD
Fluoxetine—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	4.14e-05	0.000173	CcSEcCtD
Fluoxetine—Rash—Mycophenolate mofetil—systemic lupus erythematosus	4.14e-05	0.000173	CcSEcCtD
Fluoxetine—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	4.14e-05	0.000172	CcSEcCtD
Fluoxetine—Headache—Mycophenolate mofetil—systemic lupus erythematosus	4.12e-05	0.000171	CcSEcCtD
Fluoxetine—Malaise—Methotrexate—systemic lupus erythematosus	4.11e-05	0.000171	CcSEcCtD
Fluoxetine—Vertigo—Methotrexate—systemic lupus erythematosus	4.1e-05	0.000171	CcSEcCtD
Fluoxetine—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	4.1e-05	0.000171	CcSEcCtD
Fluoxetine—Leukopenia—Methotrexate—systemic lupus erythematosus	4.08e-05	0.00017	CcSEcCtD
Fluoxetine—Urticaria—Betamethasone—systemic lupus erythematosus	4.06e-05	0.000169	CcSEcCtD
Fluoxetine—Urticaria—Dexamethasone—systemic lupus erythematosus	4.06e-05	0.000169	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	4.06e-05	0.000169	CcSEcCtD
Fluoxetine—Dizziness—Prednisolone—systemic lupus erythematosus	4.05e-05	0.000169	CcSEcCtD
Fluoxetine—Asthenia—Triamcinolone—systemic lupus erythematosus	4.04e-05	0.000168	CcSEcCtD
Fluoxetine—Body temperature increased—Betamethasone—systemic lupus erythematosus	4.04e-05	0.000168	CcSEcCtD
Fluoxetine—Body temperature increased—Dexamethasone—systemic lupus erythematosus	4.04e-05	0.000168	CcSEcCtD
Fluoxetine—Abdominal pain—Betamethasone—systemic lupus erythematosus	4.04e-05	0.000168	CcSEcCtD
Fluoxetine—Abdominal pain—Dexamethasone—systemic lupus erythematosus	4.04e-05	0.000168	CcSEcCtD
Fluoxetine—Asthenia—Methylprednisolone—systemic lupus erythematosus	4.03e-05	0.000168	CcSEcCtD
Fluoxetine—Insomnia—Prednisone—systemic lupus erythematosus	4.03e-05	0.000168	CcSEcCtD
Fluoxetine—Nausea—Cyclosporine—systemic lupus erythematosus	4e-05	0.000167	CcSEcCtD
Fluoxetine—Paraesthesia—Prednisone—systemic lupus erythematosus	4e-05	0.000167	CcSEcCtD
Fluoxetine—Pruritus—Triamcinolone—systemic lupus erythematosus	3.99e-05	0.000166	CcSEcCtD
Fluoxetine—Cough—Methotrexate—systemic lupus erythematosus	3.98e-05	0.000166	CcSEcCtD
Fluoxetine—Pruritus—Methylprednisolone—systemic lupus erythematosus	3.98e-05	0.000166	CcSEcCtD
Fluoxetine—Dizziness—Hydrocortisone—systemic lupus erythematosus	3.96e-05	0.000165	CcSEcCtD
Fluoxetine—Convulsion—Methotrexate—systemic lupus erythematosus	3.95e-05	0.000165	CcSEcCtD
Fluoxetine—Dyspepsia—Prednisone—systemic lupus erythematosus	3.92e-05	0.000163	CcSEcCtD
Fluoxetine—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	3.9e-05	0.000163	CcSEcCtD
Fluoxetine—Myalgia—Methotrexate—systemic lupus erythematosus	3.88e-05	0.000162	CcSEcCtD
Fluoxetine—Chest pain—Methotrexate—systemic lupus erythematosus	3.88e-05	0.000162	CcSEcCtD
Fluoxetine—Arthralgia—Methotrexate—systemic lupus erythematosus	3.88e-05	0.000162	CcSEcCtD
Fluoxetine—Decreased appetite—Prednisone—systemic lupus erythematosus	3.87e-05	0.000161	CcSEcCtD
Fluoxetine—Rash—Prednisolone—systemic lupus erythematosus	3.86e-05	0.000161	CcSEcCtD
Fluoxetine—Dermatitis—Prednisolone—systemic lupus erythematosus	3.86e-05	0.000161	CcSEcCtD
Fluoxetine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	3.86e-05	0.000161	CcSEcCtD
Fluoxetine—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	3.85e-05	0.00016	CcSEcCtD
Fluoxetine—Fatigue—Prednisone—systemic lupus erythematosus	3.84e-05	0.00016	CcSEcCtD
Fluoxetine—Headache—Prednisolone—systemic lupus erythematosus	3.84e-05	0.00016	CcSEcCtD
Fluoxetine—Discomfort—Methotrexate—systemic lupus erythematosus	3.84e-05	0.00016	CcSEcCtD
Fluoxetine—Constipation—Prednisone—systemic lupus erythematosus	3.81e-05	0.000159	CcSEcCtD
Fluoxetine—Vomiting—Hydrocortisone—systemic lupus erythematosus	3.81e-05	0.000159	CcSEcCtD
Fluoxetine—Rash—Hydrocortisone—systemic lupus erythematosus	3.77e-05	0.000157	CcSEcCtD
Fluoxetine—Dermatitis—Hydrocortisone—systemic lupus erythematosus	3.77e-05	0.000157	CcSEcCtD
Fluoxetine—Confusional state—Methotrexate—systemic lupus erythematosus	3.75e-05	0.000156	CcSEcCtD
Fluoxetine—Headache—Hydrocortisone—systemic lupus erythematosus	3.75e-05	0.000156	CcSEcCtD
Fluoxetine—Dizziness—Triamcinolone—systemic lupus erythematosus	3.73e-05	0.000155	CcSEcCtD
Fluoxetine—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	3.72e-05	0.000155	CcSEcCtD
Fluoxetine—Dizziness—Methylprednisolone—systemic lupus erythematosus	3.72e-05	0.000155	CcSEcCtD
Fluoxetine—Infection—Methotrexate—systemic lupus erythematosus	3.7e-05	0.000154	CcSEcCtD
Fluoxetine—Feeling abnormal—Prednisone—systemic lupus erythematosus	3.67e-05	0.000153	CcSEcCtD
Fluoxetine—Asthenia—Dexamethasone—systemic lupus erythematosus	3.67e-05	0.000153	CcSEcCtD
Fluoxetine—Asthenia—Betamethasone—systemic lupus erythematosus	3.67e-05	0.000153	CcSEcCtD
Fluoxetine—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	3.64e-05	0.000152	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	3.64e-05	0.000152	CcSEcCtD
Fluoxetine—Nausea—Prednisolone—systemic lupus erythematosus	3.64e-05	0.000152	CcSEcCtD
Fluoxetine—Pruritus—Dexamethasone—systemic lupus erythematosus	3.62e-05	0.000151	CcSEcCtD
Fluoxetine—Pruritus—Betamethasone—systemic lupus erythematosus	3.62e-05	0.000151	CcSEcCtD
Fluoxetine—Skin disorder—Methotrexate—systemic lupus erythematosus	3.62e-05	0.000151	CcSEcCtD
Fluoxetine—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	3.6e-05	0.00015	CcSEcCtD
Fluoxetine—Vomiting—Triamcinolone—systemic lupus erythematosus	3.58e-05	0.000149	CcSEcCtD
Fluoxetine—Vomiting—Methylprednisolone—systemic lupus erythematosus	3.58e-05	0.000149	CcSEcCtD
Fluoxetine—Nausea—Hydrocortisone—systemic lupus erythematosus	3.56e-05	0.000148	CcSEcCtD
Fluoxetine—Rash—Triamcinolone—systemic lupus erythematosus	3.55e-05	0.000148	CcSEcCtD
Fluoxetine—Dermatitis—Triamcinolone—systemic lupus erythematosus	3.55e-05	0.000148	CcSEcCtD
Fluoxetine—Anorexia—Methotrexate—systemic lupus erythematosus	3.55e-05	0.000148	CcSEcCtD
Fluoxetine—Rash—Methylprednisolone—systemic lupus erythematosus	3.55e-05	0.000148	CcSEcCtD
Fluoxetine—Dermatitis—Methylprednisolone—systemic lupus erythematosus	3.54e-05	0.000148	CcSEcCtD
Fluoxetine—Urticaria—Prednisone—systemic lupus erythematosus	3.54e-05	0.000147	CcSEcCtD
Fluoxetine—Headache—Triamcinolone—systemic lupus erythematosus	3.53e-05	0.000147	CcSEcCtD
Fluoxetine—Headache—Methylprednisolone—systemic lupus erythematosus	3.52e-05	0.000147	CcSEcCtD
Fluoxetine—Abdominal pain—Prednisone—systemic lupus erythematosus	3.52e-05	0.000147	CcSEcCtD
Fluoxetine—Body temperature increased—Prednisone—systemic lupus erythematosus	3.52e-05	0.000147	CcSEcCtD
Fluoxetine—Diarrhoea—Dexamethasone—systemic lupus erythematosus	3.5e-05	0.000146	CcSEcCtD
Fluoxetine—Diarrhoea—Betamethasone—systemic lupus erythematosus	3.5e-05	0.000146	CcSEcCtD
Fluoxetine—Hypotension—Methotrexate—systemic lupus erythematosus	3.48e-05	0.000145	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	3.39e-05	0.000141	CcSEcCtD
Fluoxetine—Dizziness—Dexamethasone—systemic lupus erythematosus	3.38e-05	0.000141	CcSEcCtD
Fluoxetine—Dizziness—Betamethasone—systemic lupus erythematosus	3.38e-05	0.000141	CcSEcCtD
Fluoxetine—Insomnia—Methotrexate—systemic lupus erythematosus	3.37e-05	0.00014	CcSEcCtD
Fluoxetine—Nausea—Triamcinolone—systemic lupus erythematosus	3.35e-05	0.000139	CcSEcCtD
Fluoxetine—Paraesthesia—Methotrexate—systemic lupus erythematosus	3.34e-05	0.000139	CcSEcCtD
Fluoxetine—Nausea—Methylprednisolone—systemic lupus erythematosus	3.34e-05	0.000139	CcSEcCtD
Fluoxetine—Dyspnoea—Methotrexate—systemic lupus erythematosus	3.32e-05	0.000138	CcSEcCtD
Fluoxetine—Somnolence—Methotrexate—systemic lupus erythematosus	3.31e-05	0.000138	CcSEcCtD
Fluoxetine—Hypersensitivity—Prednisone—systemic lupus erythematosus	3.28e-05	0.000137	CcSEcCtD
Fluoxetine—Dyspepsia—Methotrexate—systemic lupus erythematosus	3.28e-05	0.000137	CcSEcCtD
Fluoxetine—Vomiting—Betamethasone—systemic lupus erythematosus	3.25e-05	0.000135	CcSEcCtD
Fluoxetine—Vomiting—Dexamethasone—systemic lupus erythematosus	3.25e-05	0.000135	CcSEcCtD
Fluoxetine—Decreased appetite—Methotrexate—systemic lupus erythematosus	3.24e-05	0.000135	CcSEcCtD
Fluoxetine—Rash—Dexamethasone—systemic lupus erythematosus	3.22e-05	0.000134	CcSEcCtD
Fluoxetine—Rash—Betamethasone—systemic lupus erythematosus	3.22e-05	0.000134	CcSEcCtD
Fluoxetine—Dermatitis—Dexamethasone—systemic lupus erythematosus	3.22e-05	0.000134	CcSEcCtD
Fluoxetine—Dermatitis—Betamethasone—systemic lupus erythematosus	3.22e-05	0.000134	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	3.21e-05	0.000134	CcSEcCtD
Fluoxetine—Fatigue—Methotrexate—systemic lupus erythematosus	3.21e-05	0.000134	CcSEcCtD
Fluoxetine—Headache—Betamethasone—systemic lupus erythematosus	3.2e-05	0.000133	CcSEcCtD
Fluoxetine—Headache—Dexamethasone—systemic lupus erythematosus	3.2e-05	0.000133	CcSEcCtD
Fluoxetine—Asthenia—Prednisone—systemic lupus erythematosus	3.2e-05	0.000133	CcSEcCtD
Fluoxetine—Pain—Methotrexate—systemic lupus erythematosus	3.18e-05	0.000133	CcSEcCtD
Fluoxetine—Pruritus—Prednisone—systemic lupus erythematosus	3.15e-05	0.000131	CcSEcCtD
Fluoxetine—Feeling abnormal—Methotrexate—systemic lupus erythematosus	3.07e-05	0.000128	CcSEcCtD
Fluoxetine—Diarrhoea—Prednisone—systemic lupus erythematosus	3.05e-05	0.000127	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	3.04e-05	0.000127	CcSEcCtD
Fluoxetine—Nausea—Dexamethasone—systemic lupus erythematosus	3.04e-05	0.000127	CcSEcCtD
Fluoxetine—Nausea—Betamethasone—systemic lupus erythematosus	3.04e-05	0.000127	CcSEcCtD
Fluoxetine—Urticaria—Methotrexate—systemic lupus erythematosus	2.96e-05	0.000123	CcSEcCtD
Fluoxetine—Dizziness—Prednisone—systemic lupus erythematosus	2.94e-05	0.000123	CcSEcCtD
Fluoxetine—Abdominal pain—Methotrexate—systemic lupus erythematosus	2.94e-05	0.000123	CcSEcCtD
Fluoxetine—Body temperature increased—Methotrexate—systemic lupus erythematosus	2.94e-05	0.000123	CcSEcCtD
Fluoxetine—Vomiting—Prednisone—systemic lupus erythematosus	2.83e-05	0.000118	CcSEcCtD
Fluoxetine—Rash—Prednisone—systemic lupus erythematosus	2.81e-05	0.000117	CcSEcCtD
Fluoxetine—Dermatitis—Prednisone—systemic lupus erythematosus	2.81e-05	0.000117	CcSEcCtD
Fluoxetine—Headache—Prednisone—systemic lupus erythematosus	2.79e-05	0.000116	CcSEcCtD
Fluoxetine—Hypersensitivity—Methotrexate—systemic lupus erythematosus	2.74e-05	0.000114	CcSEcCtD
Fluoxetine—Asthenia—Methotrexate—systemic lupus erythematosus	2.67e-05	0.000111	CcSEcCtD
Fluoxetine—Nausea—Prednisone—systemic lupus erythematosus	2.65e-05	0.00011	CcSEcCtD
Fluoxetine—Pruritus—Methotrexate—systemic lupus erythematosus	2.63e-05	0.00011	CcSEcCtD
Fluoxetine—Diarrhoea—Methotrexate—systemic lupus erythematosus	2.55e-05	0.000106	CcSEcCtD
Fluoxetine—Dizziness—Methotrexate—systemic lupus erythematosus	2.46e-05	0.000103	CcSEcCtD
Fluoxetine—Vomiting—Methotrexate—systemic lupus erythematosus	2.37e-05	9.86e-05	CcSEcCtD
Fluoxetine—Rash—Methotrexate—systemic lupus erythematosus	2.35e-05	9.78e-05	CcSEcCtD
Fluoxetine—Dermatitis—Methotrexate—systemic lupus erythematosus	2.34e-05	9.77e-05	CcSEcCtD
Fluoxetine—Headache—Methotrexate—systemic lupus erythematosus	2.33e-05	9.71e-05	CcSEcCtD
Fluoxetine—Nausea—Methotrexate—systemic lupus erythematosus	2.21e-05	9.21e-05	CcSEcCtD
